Latest Pharmacotherapy Developments for Sleep Apnea, with Danny Eckert, PhD

At SLEEP 2025, Danny Eckert, PhD, discussed new drug therapies for OSA, including tirzepatide, AD109, potassium channel blockers, and acetazolamide.

Read the full article here

Related Articles